As a neurosurgery resident, how can I differentiate subdural hematoma, subdural hygroma, and subdural empyema?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 4, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Differentiating Subdural Hematoma, Subdural Hygroma, and Subdural Empyema

The key to differentiating these three subdural collections lies in imaging characteristics (CT density/MRI signal intensity), clinical presentation (trauma vs. infection), and CSF analysis when infection is suspected.

Imaging Differentiation

CT Characteristics

Subdural Hematoma:

  • Acute phase: Hyperdense (bright) crescent-shaped collection 1
  • Subacute phase: Isodense to brain (can be missed on non-contrast CT)
  • Chronic phase: Hypodense (dark), may show mixed density with sedimentation levels or heterogeneity indicating rebleeding 1
  • Convex outer border, irregular concave inner border 1

Subdural Hygroma:

  • Hypodense (CSF density) collection on CT 2
  • Signal intensity identical to CSF without blood products 3
  • May pile up with subarachnoid hemorrhage creating two-component appearance (outer hypodense hygroma, inner hyperdense blood) 2
  • Approximately 25% evolve to chronic subdural hematoma, especially in patients ≥60 years old 4

Subdural Empyema:

  • May initially mimic chronic subdural hematoma on non-contrast CT 5
  • Requires contrast-enhanced imaging for definitive diagnosis 6
  • Shows enhancement of collection margins and adjacent meninges

MRI Characteristics (Superior Modality)

MRI detects subdural collections in nearly 100% of cases and is far superior to CT for differentiation 1, 7.

Subdural Hematoma:

  • Acute: Isointense on T1, hypointense on T2
  • Early subacute: Hyperintense on T1 and T2 (methemoglobin)
  • Late subacute: Hyperintense on both sequences
  • Chronic: Isointense or hypointense on T1 (unlike chronic parenchymal hematomas which remain hyperintense) 3
  • Hemosiderin rarely seen in simple chronic hematomas
  • Rebleeding: Multiple phases of bleeding with layering, more frequent hemosiderin deposition 3

Subdural Hygroma:

  • Signal intensity identical to CSF on all sequences 3
  • T2-weighted and FLAIR sequences show CSF-like signal
  • No blood products on gradient echo or susceptibility-weighted imaging 3

Subdural Empyema:

  • Contrast enhancement is the key distinguishing feature 6
  • Shows rim enhancement and adjacent meningeal enhancement
  • DWI shows restricted diffusion (bright on DWI, dark on ADC) - this is pathognomonic for pus
  • T2-FLAIR shows hyperintense collection with surrounding edema

Clinical Differentiation

History and Presentation

Subdural Hematoma:

  • History of trauma (may be minor or remote, especially in elderly/anticoagulated patients) 8
  • Progressive headache, altered mental status, focal neurological deficits
  • Consider spontaneous intracranial hypotension if no trauma/coagulopathy/alcohol misuse 8

Subdural Hygroma:

  • Post-traumatic delayed complication 2
  • Usually clinically silent initially 2
  • May present with mild headache and consciousness disturbance
  • Clear fluid under pressure at surgery 3

Subdural Empyema:

  • Fever (often high-grade, 39°C) 5
  • Severe headache with meningismus 5
  • Rapid neurological deterioration (GCS decline)
  • Seizures are common 6
  • May have source: sinusitis, otitis, meningitis, or post-neurosurgical 6

Laboratory Findings

Subdural Empyema (Diagnostic):

  • Markedly elevated inflammatory markers: CRP >300 mg/L, procalcitonin >2 ng/mL, WBC >15 × 10⁹/L 5
  • CSF analysis (if safe to perform): protein 60-fold elevated, uncountable cells, viscous fluid 5
  • Cultures may be negative in up to 30% of cases, especially with prior antibiotics 5
  • Consider molecular diagnostics when cultures negative 5

Subdural Hematoma/Hygroma:

  • Normal inflammatory markers
  • No fever or systemic infection signs

Diagnostic Algorithm

  1. Initial CT scan: Identifies collection, determines density

    • Hyperdense → acute hematoma
    • Isodense → subacute hematoma or empyema (needs MRI)
    • Hypodense → chronic hematoma, hygroma, or empyema
  2. Clinical assessment:

    • Fever + meningismus + elevated inflammatory markers → empyema until proven otherwise
    • Trauma history + no infection signs → hematoma or hygroma
    • No trauma + orthostatic headache → consider spontaneous intracranial hypotension 8
  3. MRI with contrast (perform urgently if empyema suspected):

    • Rim enhancement + restricted diffusion → empyema 6
    • CSF signal, no enhancement, no blood products → hygroma 3
    • Blood products on gradient echo/SWI → hematoma 7

Critical Management Pitfalls

Do not mistake subdural empyema for chronic hematoma on non-contrast CT - this delays life-saving treatment 5. If clinical picture suggests infection (fever, elevated inflammatory markers, rapid deterioration), obtain contrast-enhanced MRI immediately and start empirical broad-spectrum antibiotics (meropenem + linezolid or vancomycin) 5.

Subdural empyema requires emergent craniotomy and evacuation, not burr hole drainage 6, 5. Mortality is 6-15% even with treatment 5.

For subdural hygroma, burr hole irrigation is sufficient - avoid unnecessary craniotomy 2. Monitor patients ≥60 years closely as 25% evolve to chronic subdural hematoma 4.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.